Diastase: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
m Protected "Diastase": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
|
Latest revision as of 19:49, 18 August 2015
WikiDoc Resources for Diastase |
Articles |
---|
Most recent articles on Diastase |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Diastase at Clinical Trials.gov Clinical Trials on Diastase at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Diastase
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Diastase Risk calculators and risk factors for Diastase
|
Healthcare Provider Resources |
Causes & Risk Factors for Diastase |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A diastase (from Greek διαστασις, "separation") is any one of a group of enzymes which catalyses the breakdown of starch into maltose. It was the first type of enzyme discovered, in 1833, by Anselme Payen, who found it in malt solution. Today, diastase means any α-, β-, or γ-amylase (all of them hydrolases) that can break down carbohydrates.
The commonly used -ase suffix for naming enzymes was derived from the name diastase.
External links
- A09AA01 (WHO)
- Diastase at the US National Library of Medicine Medical Subject Headings (MeSH)